Afoxolaner 11.3 Mg Chewable Tablets
1,048 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,048
Total Reports
21
Deaths Reported
200.0%
Death Rate
Active Ingredients
Afoxolaner 11.3 Mg Chewable Tablets
Administration Routes
OralUnknownOther
Species Affected
Dog 870
Unknown 174
Human 2
Cat 2
Most Affected Breeds
Terrier - Yorkshire 219
Unknown 182
Dog (unknown) 167
Shih Tzu 99
Poodle - Toy 37
Crossbred Canine/dog 36
Maltese 35
Chihuahua 30
Poodle - Miniature 29
Pinscher - Miniature 28
Most Reported Reactions
Lack of efficacy (tick) 244
Skin disorders NOS 202
Vomiting 185
Lack of efficacy (flea) 152
Diarrhoea 72
Lethargy (see also Central nervous system depression in 'Neurological') 67
Lack of efficacy (ectoparasite) - NOS 57
Underfilling, Container 42
Emesis 40
Scratching 38
Tablets, Abnormal 36
Pruritus 34
Outcome Breakdown
Outcome Unknown
615 (70.3%)
Recovered/Normal
209 (23.9%)
Ongoing
27 (3.1%)
Died
19 (2.2%)
Recovered with Sequela
3 (0.3%)
Euthanized
2 (0.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.